Advertisement
UK markets open in 5 hours 48 minutes

  • NIKKEI 225

    38,023.07
    -437.01 (-1.14%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.66
    -0.15 (-0.18%)
     

  • GOLD FUTURES

    2,331.00
    -7.40 (-0.32%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,783.00
    -1,821.51 (-3.40%)
     

  • CMC Crypto 200

    1,394.10
    -30.00 (-2.11%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

European shares hit 1-year high on M&A deal, Actelion soars

Reuters - UK Focus

LONDON, Jan 26 (Reuters) - European shares climbed to a one-year high on Thursday after news that Johnson & Johnson (NYSE: JNJ - news) will buy the Swiss biotech firm Actelion (LSE: 0QMN.L - news) in a $30 billion deal.

The U.S. healthcare giant will make an all-cash purchase that includes spinning off Actelion's research and development pipeline. The acquisition gives J&J access to the Swiss group's line-up of high-price, high-margin medicines for rare diseases.

Actelion's shares surged 20 percent.

The broader market also got support from some positive earnings reports. Franco-Italian chipmaker STMicroelectronics (Amsterdam: ST8.AS - news) rose more than 6 percent after posting in-line results for the final quarter of 2016, driven by solid phone and car part sales and improved factory utilisation.

The pan-European STOXX 600 index was trading 0.6 percent higher by 0819 GMT after hitting its highest level since December 2015. Germany's DAX rose to its highest since May 2015 and was last quoted 0.7 percent higher. (Reporting by Atul Prakash; Editing by Kevin Liffey)